BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1663078)

  • 41. Early and late CNS-effects of corona virus infection in rats.
    Nagashima K; Wege H; ter Meulen V
    Adv Exp Med Biol; 1978; 100():395-409. PubMed ID: 211826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adaptation of coronavirus JHM to persistent infection of murine sac(-) cells.
    Baybutt HN; Wege H; Carter MJ; ter Meulen V
    J Gen Virol; 1984 May; 65 ( Pt 5)():915-24. PubMed ID: 6327888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coronavirus-JHM-induced demyelinating encephalomyelitis in rats. Analysis of the intrathecal immune response.
    Dörries R; Schwender S; Wege H; Harms H; Watanabe R; ter Meulen V
    Ann N Y Acad Sci; 1988; 540(1):663-4. PubMed ID: 2849910
    [No Abstract]   [Full Text] [Related]  

  • 44. Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease.
    Fleming JO; Trousdale MD; Bradbury J; Stohlman SA; Weiner LP
    Microb Pathog; 1987 Jul; 3(1):9-20. PubMed ID: 2848172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experimental sialodacryoadenitis virus infection in severe combined immunodeficient mice.
    Percy DH; Williams KL; Croy BA
    Can J Vet Res; 1991 Jan; 55(1):89-90. PubMed ID: 1653101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis.
    Watanabe R; Wege H; ter Meulen V
    Nature; 1983 Sep 8-14; 305(5930):150-3. PubMed ID: 6310411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The time course of the immune response to experimental coronavirus infection of man.
    Callow KA; Parry HF; Sergeant M; Tyrrell DA
    Epidemiol Infect; 1990 Oct; 105(2):435-46. PubMed ID: 2170159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune mediated clearance of JHM virus from the central nervous system.
    Sussman MA; Fleming JO; Allen H; Stohlman SA
    Adv Exp Med Biol; 1987; 218():399-410. PubMed ID: 2829552
    [No Abstract]   [Full Text] [Related]  

  • 49. In vivo and in vitro models of demyelinating disease. XVII. The infectious process in athymic rats inoculated with JHM virus.
    Sorensen O; Saravani A; Dales S
    Microb Pathog; 1987 Feb; 2(2):79-90. PubMed ID: 2853273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Host and virus factors associated with CNS cellular tropism leading to encephalomyelitis or demyelination induced by the JHM strain of mouse hepatitis virus.
    Knobler RL; Haspel MV; Dubois-Dalcq M; Lampert PW; Oldstone MB
    Adv Exp Med Biol; 1981; 142():341-8. PubMed ID: 6278890
    [No Abstract]   [Full Text] [Related]  

  • 51. In vivo and in vitro models of demyelinating diseases. XXIV. The infectious process in cyclosporin A treated Wistar Lewis rats inoculated with JHM virus.
    Zimmer MJ; Dales S
    Microb Pathog; 1989 Jan; 6(1):7-16. PubMed ID: 2543885
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coronavirus JHM-induced demyelinating encephalomyelitis in rats: influence of immunity on the course of disease.
    Wege H; Watanabe R; Koga M; Ter Meulen V
    Prog Brain Res; 1983; 59():221-31. PubMed ID: 6320266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of maternal immunity on the outcome of murine coronavirus JHM infection in suckling mice.
    Pickel K; Müller MA; ter Meulen V
    Med Microbiol Immunol; 1985; 174(1):15-24. PubMed ID: 2987653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurovirulence of murine coronavirus JHM temperature-sensitive mutants in rats.
    Wege H; Koga M; Watanabe R; Nagashima K; ter Meulen V
    Infect Immun; 1983 Mar; 39(3):1316-24. PubMed ID: 6301992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of the intracerebral antibody response on the clinical course of a virus-induced demyelination in a rat model system.
    Dörries R; Imrich H; Hein A; Czub S; Schwender S
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):18-20. PubMed ID: 7964844
    [No Abstract]   [Full Text] [Related]  

  • 56. Coronavirus-induced CNS disease: a model for virus-induced demyelination.
    Buchmeier MJ; Dalziel RG; Koolen MJ
    J Neuroimmunol; 1988 Dec; 20(2-3):111-6. PubMed ID: 2848860
    [No Abstract]   [Full Text] [Related]  

  • 57. Analysis of age-dependent resistance to murine coronavirus JHM infection in mice.
    Pickel K; Müller MA; ter Meulen V
    Infect Immun; 1981 Dec; 34(3):648-54. PubMed ID: 6277786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease.
    Fazzini E; Fleming J; Fahn S
    Mov Disord; 1992; 7(2):153-8. PubMed ID: 1316552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Experimental coronavirus encephalomyelitis in mice].
    Maĭorova LP; Konovalov GV; Ogurtsov RP; Smorodintsev AA
    Vopr Virusol; 1987; 32(1):99-105. PubMed ID: 3033910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coronavirus infects and causes demyelination in primate central nervous system.
    Murray RS; Cai GY; Hoel K; Zhang JY; Soike KF; Cabirac GF
    Virology; 1992 May; 188(1):274-84. PubMed ID: 1314455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.